Literature DB >> 8530164

Differentially regulated expression of human IgG Fc receptor class III genes.

J E Gessner1, T Grussenmeyer, R E Schmidt.   

Abstract

The expression of the human Fc receptor with low affinity for IgG (Fc gamma RIII, CD16) encoded by the Fc gamma RIII-A or Fc gamma RIII-B genes is restricted to natural killer (NK), a subset of T cells and macrophages or neutrophils (PMN). The genetic heterogeneity of Fc gamma RIII generates alternative membrane-anchored proteins with distinct signaling capacities when cross-linked by immune complexes. Of great importance is the characterization of the regulatory gene elements directing the expression of a particular Fc gamma RIII isoform to a given specific cell type. Molecular characterization of the Fc gamma RIII-A and Fc gamma RIII-B genes has revealed that the promoter regions display distinct tissue-specific transcriptional activities. In addition, the differential Fc gamma RIII-A/B gene activation can be regulated by enhancer elements located in the more upstream and intron regions. Transcription initiation in NK cells occurs also outside the normal promoter region by a second independent Fc gamma RIII-A promoter. Analysis of the additional Fc gamma RIIIa2-4 transcripts suggests the expression of novel, as yet unknown Fc gamma RIII receptor isoforms on NK cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8530164     DOI: 10.1016/s0171-2985(11)80564-4

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  2 in total

1.  A human CD4+ T-cell line expresses functional CD64 (Fc gamma RI), CD32 (Fc gamma RII), and CD16 (Fc gamma RIII) receptors but these do not enhance the infectivity of HIV-1-IgG complexes.

Authors:  L McLain; N J Dimmock
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

2.  Epigenetic and Posttranscriptional Regulation of CD16 Expression during Human NK Cell Development.

Authors:  Aaron R Victor; Christoph Weigel; Steven D Scoville; Wing Keung Chan; Kelsey Chatman; Mary M Nemer; Charlene Mao; Karen A Young; Jianying Zhang; Jianhua Yu; Aharon G Freud; Christopher C Oakes; Michael A Caligiuri
Journal:  J Immunol       Date:  2017-12-11       Impact factor: 5.422

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.